Meinhardt MW
Institute of Psychopharmacology, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany. marcus.meinhardt@zi-mannheim.de.
ArticlePsilocybin
Epigenome-wide association study of psilocybin-induced methylome changes in alcohol use disorder.
ArticlePsilocybin
Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons.
ArticleKetamine
(R)-Ketamine reduces alcohol intake and alcohol seeking induced by reconsolidation of alcohol-related memories in female Marchigian Sardinian alcohol-preferring rats.
ArticlePsilocybin
Therapeutic Use of Psilocybin in Depression: a Systematic Review of Clinical Evidence.
PreprintPsilocybin
Epigenome-wide Association Study of Psilocybin-Induced Methylome Changes in Alcohol Use Disorder
ArticleKetamine
A new module in the drug development process: preclinical multi-center randomized controlled trial of R-ketamine on alcohol relapse.
ArticlePsilocybin
Prefrontal electrophysiological biomarkers and mechanism-based drug effects in a rat model of alcohol addiction.
PreprintPsilocybin
Prefrontal Electrophysiological Biomarkers and Mechanism-Based Drug Effects in a Rat Model of Alcohol Addiction
ArticlePsilocybin
Psilocybin-induced default mode network hypoconnectivity is blunted in alcohol-dependent rats.
ArticlePsychedelics
The ego in psychedelic drug action - ego defenses, ego boundaries, and the therapeutic role of regression.
ArticlePsilocybin
Mini-review: The neurobiology of treating substance use disorders with classical psychedelics.
ArticlePsilocybin
Psychedelic Targeting of Metabotropic Glutamate Receptor 2 and Its Implications for the Treatment of Alcoholism.
ArticlePsilocybin